Risk Associated With SARS-CoV-2 Vaccination, Guillain-Barré Syndrome Is Slight, Analysis Finds

MedPage Today (1/16, George) reports, “Risk associated with SARS-CoV-2 vaccination and Guillain-Barré syndrome (GBS) – or possibly with Bell’s palsy – is slight and shouldn’t change vaccine recommendations, reviewers concluded.” An analysis of almost 70 “papers on neuro-immunologic disease and COVID vaccines showed that 11 studies specifically assessed relationships with GBS.” Ten of those “studies found links between GBS and the adenoviral vector vaccines from Johnson & Johnson or AstraZeneca.” One paper “also reported an association between GBS and Pfizer’s BNT162b2 mRNA vaccine (Comirnaty).” The findings were published in JAMA Neurology.